Učitavanje...
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
AIM: To evaluate the association between alpha-1 antitrypsin deficiency (A1ATD) and hepatocellular carcinoma (HCC) in patients with end-stage liver disease (ESLD). METHODS: Patients with cirrhosis and ESLD referred to the Cleveland Clinic Foundation for liver transplantation between 2003 and 2014 we...
Spremljeno u:
| Izdano u: | World J Hepatol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450206/ https://ncbi.nlm.nih.gov/pubmed/26052388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i10.1427 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|